John Wiley & Sons, Inc. (WLY) Stock Price & Analysis
John Wiley & Sons, Inc. (WLY) rose 1.70% to USD 49.55 as of July 25, 2026 at 03:44 UTC, according to Nexqual real-time market data.
WLY last closed at USD 48.72; the session ranged USD 48.76–49.82 on volume of 186,825 shares. Market capitalization is $2.52B, with a 52-week range of USD 28.38–53.24 (NYQ). Source: Nexqual, July 25, 2026 at 03:44 UTC.
Key Statistics (as of July 25, 2026 at 03:44 UTC)
| Price | USD 49.55 |
|---|---|
| Change | ▲ 1.70% (up) |
| Previous Close | USD 48.72 |
| Open | USD 48.72 |
| Day Range | USD 48.76 – 49.82 |
| 52-Week Range | USD 28.38 – 53.24 |
| Volume | 186,825 shares |
| Market Cap | $2.52B |
| Exchange | NYQ |
Technical Analysis (WLY)
Nexqual's technical model rates WLY "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:44 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.72 (neutral) |
| vs SMA50 | Above (USD 45.95) |
| MACD | 1.04 (positive) |
Analyst Ratings (WLY)
Wall Street analysts rate WLY "Buy" based on 1 analysts, with a mean price target of USD 68 (range USD 68–68), per Nexqual as of July 25, 2026 at 03:44 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 68 |
| High Target | USD 68 |
| Low Target | USD 68 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (WLY)
| Next Earnings Date | 2026-09-03 |
|---|---|
| EPS Estimate | USD 0.4 |
| Revenue Estimate | $380.20M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-04-30 | USD 1.67 vs est 1.65 ▲ beat |
| 2026-01-31 | USD 0.97 vs est 0.86 ▲ beat |
| 2025-10-31 | USD 1.1 vs est 0.97 ▲ beat |
| 2025-07-31 | USD 0.49 vs est 0.5 ▼ miss |
Source: Nexqual, July 25, 2026 at 03:44 UTC.
Financials & Fundamentals (WLY)
| Total Revenue | $1.68B |
|---|---|
| Revenue Growth (YoY) | +1.20% |
| Gross Margin | +74.26% |
| Operating Margin | +24.71% |
| Profit Margin | +13.22% |
| ROE | +27.69% |
| Debt / Equity | 90.75 |
| Current Ratio | 0.54 |
| Total Cash | $75.62M |
| Total Debt | $769.77M |
| Free Cash Flow | $202.07M |
Source: Nexqual, July 25, 2026 at 03:44 UTC.
Financial Health Score (WLY)
Nexqual rates John Wiley & Sons, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:44 UTC.
| Growth | Weak — Revenue -0% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 74%, operating 25% |
| Balance Sheet | Weak — $76M cash vs $770M debt |
| Cash Flow | Solid — FCF $202M, 12% margin |
| Efficiency | Strong — ROE 28%, ROA 6.8% |
Ownership (WLY)
| Insider Ownership | +9.78% |
|---|---|
| Institutional Ownership | +104.89% |
| Shares Outstanding | 42.00M |
| Float | 38.61M |
| Short % of Float | +13.69% |
Source: Nexqual, July 25, 2026 at 03:44 UTC.
Leadership (WLY)
John Wiley & Sons, Inc. is led by Matthew S. Kissner (age 71), President, CEO & Employee Director, per Nexqual as of July 25, 2026 at 03:44 UTC.
| President, CEO & Employee Director | Matthew S. Kissner (age 71) |
|---|---|
| Non-Executive Chairman | Jesse Caleb Wiley (age 54) |
| Senior Vice President of Business Transformation | Christopher F. Caridi (age 58) |
| Executive VP & CFO | Craig Albright (age 55) |
| Executive Vice President of Technology & Operations | Andrew Weber (age 57) |
Major Backers & Investors (WLY)
Notable institutional backers of John Wiley & Sons, Inc. include Neuberger Berman Group, LLC, Schroder Investment Management Group, Brown Advisory Inc., according to Nexqual as of July 25, 2026 at 03:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Neuberger Berman Group, LLC | 11.17% |
| Schroder Investment Management Group | 5.67% |
| Brown Advisory Inc. | 4.18% |
| Bank of Montreal /CAN/ | 3.79% |
| Silvercrest Asset Management Group, LLC | 2.32% |
| -SSgA SPDR ETFS Europe I-SPDR S&P Glbl Div Aristocrats UCITS ETF | 1.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 22.78% |
| Vanguard Group | 17.32% |
| State Street | 5.18% |
| Dimensional Fund Advisors | 4.36% |
Source: Nexqual, July 25, 2026 at 03:44 UTC.
From John Wiley & Sons, Inc.'s Latest SEC 10-K Filing (filed 2026-06-24)
Key Strengths & Strategy (as disclosed to the SEC)
- Research Exchange (ReX) is Wiley's proprietary end-to-end manuscript submission and peer review platform, designed to streamline the publishing workflow for authors, editors, and reviewers.
- Digital books are delivered to intermediaries and aggregators, including Amazon, Apple, and Google, for sale to individuals, libraries, or distinct communities in various industry-standard or custom formats.
- AI and data analytics is our emerging growth engine, leveraging our proprietary content, data, and partnership ecosystem for corporate models and applications.
Partnerships
- As with our subscription portfolio, a number of the Gold Open Access Journals are published under contract for, or in partnership with, prestigious societies, including the American Geophysical Union, the American Heart Association, and the British Ecological Society.
- Through our alliance with The Cochrane Collaboration, we publish The Cochrane Library , a premier source of high-quality independent evidence to inform healthcare decision-making.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WLYB | John Wiley & Sons, Inc. | USD 50.21 | ▼ 0.5% |
| ESAB | ESAB Corporation | USD 84.44 | ▲ 0.49% |
| MLKN | MillerKnoll, Inc. | USD 22.08 | ▲ 0.82% |
| STGW | Stagwell Inc. | USD 7.42 | ▲ 5.1% |
| EPAC | Enerpac Tool Group Corp. | USD 34.67 | ▲ 0.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:44 UTC. This page is informational and not investment advice.